UltraGreen.ai clarifies media report; keeps FY2026 outlook unchanged

SGX Filings

Aug 20

UltraGreen.ai Limited on Aug, 20 2026 issued a statement addressing an Aug, 19 2026 article in The Business Times, noting that recent U.S. regulatory approvals obtained by peers Zydus Lifesciences and Provepharm are publicly available information and do not automatically translate into commercial launches or market penetration.

The company emphasised that references in the article to competitors’ manufacturing costs and potential pricing scenarios were opinions of third-party analysts and are not endorsed by UltraGreen.ai.

Based on current information, the board said there has been no material change to its business or outlook and it is maintaining its previously announced FY2026 revenue guidance of US$175 million to US$185 million. Revenue in the second half of FY2026 is still expected to surpass that of the first half.

The clarification was released by Executive Director and Chief Executive Officer Ravinder Sajwan. Citigroup Global Markets Singapore and DBS Bank remain joint issue managers and global coordinators for UltraGreen.ai’s listing on the Singapore Exchange Mainboard.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1148078055"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1148078055\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1148078055?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-20 13:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1148078055","market":"sg","top_or_hot":-1,"title":"UltraGreen.ai clarifies media report; keeps FY2026 outlook unchanged","media":"SGX Filings","content":"<p>UltraGreen.ai Limited on Aug, 20 2026 issued a statement addressing an Aug, 19 2026 article in The Business Times, noting that recent U.S. regulatory approvals obtained by peers Zydus Lifesciences and Provepharm are publicly available information and do not automatically translate into commercial launches or market penetration.</p>\n<p>The company emphasised that references in the article to competitors’ manufacturing costs and potential pricing scenarios were opinions of third-party analysts and are not endorsed by UltraGreen.ai.</p>\n<p>Based on current information, the board said there has been no material change to its business or outlook and it is maintaining its previously announced FY2026 revenue guidance of US$175 million to US$185 million. Revenue in the second half of FY2026 is still expected to surpass that of the first half.</p>\n<p>The clarification was released by Executive Director and Chief Executive Officer Ravinder Sajwan. Citigroup Global Markets Singapore and DBS Bank remain joint issue managers and global coordinators for UltraGreen.ai’s listing on the Singapore Exchange Mainboard.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UltraGreen.ai clarifies media report; keeps FY2026 outlook unchanged</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUltraGreen.ai clarifies media report; keeps FY2026 outlook unchanged\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1083912268\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">SGX Filings </p>\n<p class=\"h-time\">2026-08-20 13:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>UltraGreen.ai Limited on Aug, 20 2026 issued a statement addressing an Aug, 19 2026 article in The Business Times, noting that recent U.S. regulatory approvals obtained by peers Zydus Lifesciences and Provepharm are publicly available information and do not automatically translate into commercial launches or market penetration.</p>\n<p>The company emphasised that references in the article to competitors’ manufacturing costs and potential pricing scenarios were opinions of third-party analysts and are not endorsed by UltraGreen.ai.</p>\n<p>Based on current information, the board said there has been no material change to its business or outlook and it is maintaining its previously announced FY2026 revenue guidance of US$175 million to US$185 million. Revenue in the second half of FY2026 is still expected to surpass that of the first half.</p>\n<p>The clarification was released by Executive Director and Chief Executive Officer Ravinder Sajwan. Citigroup Global Markets Singapore and DBS Bank remain joint issue managers and global coordinators for UltraGreen.ai’s listing on the Singapore Exchange Mainboard.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ULG.SI","symbol_name":"优创康智有限公司","start_time":0,"source_url":"","article_id":"1148078055","we_media_id":"1083912268","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1148078055","pubTimestamp":1787202784,"columns":[{"name":"Earnings Express","id":26,"label_key":"express"}],"sourceInfo":null,"weMediaInfo":{"media_name":"SGX Filings","introduction":"Fastest News on SGX Filings ","home_visible":1,"id":"1083912268","head_image":"https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39"},"summary":"UltraGreen.ai Limited on Aug, 20 2026 issued a statement addressing an Aug, 19 2026 article in The Business Times, noting that recent U.S. regulatory approvals obtained by peers Zydus Lifesciences...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ULG.SI":"优创康智有限公司"},"translate_title":"UltraGreen.ai 澄清媒体报道；维持 2026 财年展望不变","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ULG.SI":1},"content_text":"UltraGreen.ai Limited on Aug, 20 2026 issued a statement addressing an Aug, 19 2026 article in The Business Times, noting that recent U.S. regulatory approvals obtained by peers Zydus Lifesciences and Provepharm are publicly available information and do not automatically translate into commercial launches or market penetration.\nThe company emphasised that references in the article to competitors’ manufacturing costs and potential pricing scenarios were opinions of third-party analysts and are not endorsed by UltraGreen.ai.\nBased on current information, the board said there has been no material change to its business or outlook and it is maintaining its previously announced FY2026 revenue guidance of US$175 million to US$185 million. Revenue in the second half of FY2026 is still expected to surpass that of the first half.\nThe clarification was released by Executive Director and Chief Executive Officer Ravinder Sajwan. Citigroup Global Markets Singapore and DBS Bank remain joint issue managers and global coordinators for UltraGreen.ai’s listing on the Singapore Exchange Mainboard.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX,express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}